TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
ACAD

ACADIA Pharmaceuticals Inc

Healthcare · Biotechnology

20.70$ -6.8% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

ACADIA Pharmaceuticals Inc (ACAD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,743 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ACAD
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
633 749 855 914 977 1,188 1,132 1,226 1,331 1,564 1,605 1,743
499 616 675 729 788 938 871 961 1,076 1,062 1,096 1,225
98 189 205 177 155 320 218 254 258 178 282 385
346 439 471 501 565 756 682 762 847 820 851 956
95 102 100 110 98 105 114 120 139 148 148 166
21 36 62 72 61 22 23 26 29 35 32 32
56 – – – – – – – – – – –
– 0.0 – – – – – – – – – –
67 65 110 108 106 120 117 114 112 109 106 103
270 317 391 397 400 455 367 403 413 337 357 436
210 254 331 338 344 395 303 330 357 277 306 361
9.0 9.4 10 10 8.9 10.0 11 12 12 12 12 14
12 18 19 20 19 16 18 20 22 11 12 45
362 432 464 517 577 733 765 822 917 1,227 1,248 1,307
-2,477 -2,431 -2,414 -2,381 -2,348 -2,204 -2,185 -2,159 -2,087 -1,813 -1,810 -1,778
164 167 167 166 166 166 168 169 171 171 173 173

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?